190 Bath Road
Slough SL1 3XE
Ipsen Limited is the UK subsidiary of Ipsen, a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2012.
Ipsen Limited is the UK subsidiary of Ipsen, a global specialty-driven pharmaceutical company with total sales exceeding €1.2 billion in 2012. Ipsen’s ambition is to become a global leader in the treatment of targeted debilitating diseases with a development strategy supported by three franchises: endocrinology, neurology and uro-oncology. Moreover, the Group has an active policy of partnerships. Research and Development is focused on innovative patient-driven programmes in the areas of peptides and toxins. In 2012, R&D expenditure totalled more than €250 million, greater than 20% of Group sales. The Group has a total worldwide staff of close to 4,900 employees.
Ipsen has a strong commitment to the field of endocrinology with an active research and development programme. The Company has supported the Society since 1997 and in addition to its corporate sponsorship, is also pleased to continue to provide financial support for the Society for Endocrinology Acromegaly Register.
For more information on Ipsen, visit our website at www.ipsen.co.uk